Objective: Uterine compression sutures such as modified B-Lynch suture or multiple square-shaped sutures of uterine body are simple methods for control of postpartum hemorrhage refractory to medical treatment. We evaluated the treatment outcome and morbidity of uterine compression sutures and analyzed clinical findings of patients undergone uterine compression sutures and postpartum hysterectomy. Methods: From January 2005 through December 2008, we retrospectively reviewed the medical records of patients undergone uterine compression sutures or postpartum hysterectomy. We analyzed success rates of preserving uterus of uterine compression sutures according to operative indications and mode of delivery and compared maternal characteristics, operative findings, morbidities and mortality with those of postpartum hysterectomy. Results: The frequency of uterine compression sutures for control of massive postpartum hemorrhage was 0.24% (73/30,677). The success rates of preserving uterus were 85.1% in uterine atony, 80.9% in placenta previa, and 40.0% in placenta accreta (P=0.051). The rates of preserving uterus of uterine compression sutures after vaginal delivery and cesarean section were 50.0% and 82.6%, respectively (P=0.164). The frequencies of postoperative morbidities such as disseminated intravascular coagulation, pulmonary edema, ileus were not different between immediate hysterectomy and hysterectomy after uterine compression sutures. There was no maternal mortality. Conclusion: Uterine compression suture was successful method for control of postpartum hemorrhage resulting from uterine atony and placenta previa.We suggest the use of uterine compression sutures as the first-line operation for control of postpartum hemorrhage.

Genetic Medicine facial features of frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, genu varum and trident hands. 3) ACH is inherited as an autosomal dominant trait with 100% penetrance. More than 90% of affected individuals have de novo mutations associated with increased paternal age. 4, 5) The gene responsible for achondroplasia, fibroblast growth factor receptor

No abstract